Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Pharmacia & Upjohn prepares MMP inhibitors

Jan. 13, 1998

Selective COX-2 inhibitors under study at Merck Frosst

Jan. 13, 1998

Effects of neutrophil elastase inhibitor MDL-101146 in two arthritis models

Jan. 12, 1998

PLA2 inhibitors described by Santen

Jan. 8, 1998

COX-2 inhibitors under study at Abbott

Jan. 8, 1998

Chiroscience discloses new MMP/TNF inhibitors

Jan. 7, 1998

Anika files for U.S. approval of osteoarthritis Rx

Jan. 5, 1998

COX-2 inhibitors reported by UPSA

Jan. 5, 1998

VX-740 advances in preclinical studies

Jan. 2, 1998

UPSA claims new COX-2 inhibitors for inflammation, pain and other disorders

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...